ARTICLE | Top Story
Ardelyx, AZN in deal for NHE3 inhibitors
October 9, 2012 12:38 AM UTC
Ardelyx Inc. (Fremont, Calif.) granted AstraZeneca plc (LSE:AZN; NYSE:AZN) exclusive, worldwide rights to its non-absorbed solute carrier family 9 sodium hydrogen exchanger member 3 ( SLC9A3; NHE3) in...